RegeneRx

RegeneRx Pipeline

RegeneRx Biopharmaceuticals, Inc. is a clinical-stage drug development company focused on tissue protection and repair with an extensive
portfolio of product candidates for first-in-class therapeutic peptides.

Latest News:

June 29, 2009
NYSE Amex Accepts RegeneRx Plan of Compliance


June 22, 2009
RegeneRx Working with U.S. Military to Test Tβ4 Against Exposure to Chemical Agents in the Eye


May 5, 2009
RegeneRx Receives Australian Patent for Treating Eye Disorders with Tβ4